Chemoinformaics analysis of Aristolochic acid IV
Molecular Weight | 371.301 | nRot | 4 |
Heavy Atom Molecular Weight | 358.197 | nRig | 22 |
Exact Molecular Weight | 371.064 | nRing | 4 |
Solubility: LogS | -4.389 | nHRing | 1 |
Solubility: LogP | 3.901 | No. of Aliphatic Rings | 1 |
Acid Count | 1 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 3 |
nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 13 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 14 |
No. of Oxygen atom | 8 | No. of Arom Bond | 16 |
nHA | 7 | APOL | 46.2443 |
nHD | 1 | BPOL | 22.0197 |
QED | 0.421 |
Synth | 2.673 |
Natural Product Likeliness | 0.641 |
NR-PPAR-gamma | 0.584 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.006 |
Pgp-sub | 0 |
HIA | 0.004 |
CACO-2 | -4.828 |
MDCK | 0.0000332 |
BBB | 0.024 |
PPB | 0.918941 |
VDSS | 0.737 |
FU | 0.0853338 |
CYP1A2-inh | 0.745 |
CYP1A2-sub | 0.756 |
CYP2c19-inh | 0.144 |
CYP2c19-sub | 0.1 |
CYP2c9-inh | 0.578 |
CYP2c9-sub | 0.637 |
CYP2d6-inh | 0.729 |
CYP2d6-sub | 0.161 |
CYP3a4-inh | 0.231 |
CYP3a4-sub | 0.04 |
CL | 6.026 |
T12 | 0.429 |
hERG | 0.059 |
Ames | 0.917 |
ROA | 0.058 |
SkinSen | 0.771 |
Carcinogencity | 0.914 |
EI | 0.473 |
Respiratory | 0.936 |
NR-Aromatase | 0.065 |
Antiviral | Yes |
Prediction | 0.660983 |